JOURNAL ARTICLE
[Ambulatory CT-assisted thoracic sympathetic block as an additional approach to treatment of complex regional pain syndromes after sport injuries].
Zeitschrift Für Orthopädie und Unfallchirurgie 2008 November
AIM: Also after bagatelle trauma, some patients can develop a complex regional pain syndrome (CRPS). The limb concerned usually shows a marked temperature difference to the contralateral side. Apart from a doughy swelling, the patient is impaired in particular by burning pain and a restricted range of motion. The objective of the present study was to examine the influence of early thoracic sympathetic nerve blockade on the basis of clinical and quantified blood flow parameters.
METHODS: In 7 young patients (average age 17.7 [15-21] years) with a clinically developing type 1 CRPS after sport injuries (mountain bike, bike, skateboard, hockey and go-kart accidents), occult injury and ligament lesions were ruled out using conventional imaging and MRI. In addition to pain-adapted physiotherapy and pharmacotherapy with analgesics and calcitonin, sympathetic nerve blockade was performed three times at two-day intervals. The CT-assisted puncture was performed in the prone position at the level of the intervertebral space of the 2nd/3rd thoracic vertebral bodies. In the correct paravertebral position, a 10-cm long, 22 G Seibel-Grönemeier needle was used for the successive injection of 6-10 ml Carbostesin 0.5 %. By adding a small amount of contrast medium, it was possible to visualise clearly the distribution of the sympathicolytic agent in the control scan in each case. Before and after the intervention, colour-coded duplex sonography (CCDS) of the affected limb arteries was performed on all patients.
RESULTS: The injection needle was correctly placed in all patients, without complications. The medication mixture was observed to have distributed properly. After the intervention, all patients reported the immediate onset of marked pain relief, whereby they recovered fully over the further course. The increase in peripheral blood flow was shown by a significant improvement in flow in the CCDS.
CONCLUSION: Outpatient CT-assisted temporary sympathetic nerve blockade is an effective and low-complication therapeutic option for the supportive treatment of patients with CRPS.
METHODS: In 7 young patients (average age 17.7 [15-21] years) with a clinically developing type 1 CRPS after sport injuries (mountain bike, bike, skateboard, hockey and go-kart accidents), occult injury and ligament lesions were ruled out using conventional imaging and MRI. In addition to pain-adapted physiotherapy and pharmacotherapy with analgesics and calcitonin, sympathetic nerve blockade was performed three times at two-day intervals. The CT-assisted puncture was performed in the prone position at the level of the intervertebral space of the 2nd/3rd thoracic vertebral bodies. In the correct paravertebral position, a 10-cm long, 22 G Seibel-Grönemeier needle was used for the successive injection of 6-10 ml Carbostesin 0.5 %. By adding a small amount of contrast medium, it was possible to visualise clearly the distribution of the sympathicolytic agent in the control scan in each case. Before and after the intervention, colour-coded duplex sonography (CCDS) of the affected limb arteries was performed on all patients.
RESULTS: The injection needle was correctly placed in all patients, without complications. The medication mixture was observed to have distributed properly. After the intervention, all patients reported the immediate onset of marked pain relief, whereby they recovered fully over the further course. The increase in peripheral blood flow was shown by a significant improvement in flow in the CCDS.
CONCLUSION: Outpatient CT-assisted temporary sympathetic nerve blockade is an effective and low-complication therapeutic option for the supportive treatment of patients with CRPS.
Full text links
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app